Dr. Nagy received his MD degree from the University of Pecs, Hungary in 1989. His interest in pursuing a career as a physician scientist led him to Purdue University, where he worked under the mentorship of Dr. Howard Zalkin, earning his PhD in Biochemistry in 1995. Subsequently, he completed an Anatomic Pathology residency and a Molecular Genetic Pathology fellowship at Stanford University, followed by postdoctoral research training in Michael Cleary’s laboratory.
Over the last decade of his career, Dr. Nagy has acted as Principal Investigator on multiple NIH funded studies and trained over twenty postdoctoral fellows and pathologists in molecular pathology.
Before joining MNG in 2016, Dr. Nagy served as Associate Director of the Personalized Genomic Medicine Laboratory in the Department of Pathology and Cell Biology at Columbia University Medical Center. He has established an array of clinical next-generation sequencing tests both for constitutional and cancer samples including whole exome and transcriptome testing. At MNG he is continuing his groundbreaking work on developing computational tools to improve the clinical specificity and sensitivity of next-generation sequencing data analysis and mutation reporting.
Dr. Nagy is board certified in Anatomic and Molecular Genetic Pathology.
Dr. Hyland received his doctorate in biochemistry from Brunel University, United Kingdom in 1980. His fellowships included Gustave Roussy Institute, Department of Biochemistry and Enzymology in Paris and the Department of Child Health, Institute of Child Health at the University of London.
In 1989 Dr. Hyland moved from the Institute of Child Health in London, where he had advanced to a lecturer in Biochemistry, to the Baylor Research Institute in Dallas, Texas where he held the positions of Senior Research Scientist at the Baylor Research Institute, Adjunct professor of Neurology at the University of Texas, Southwestern Medical Center and Professor of Biomedical Sciences at Baylor University.
In 2004, he moved to Atlanta to join Horizon Molecular Medicine, which became Medical Neurogenetics LLC in 2008.
In a career spanning 35 years, he has led numerous grant funded research teams in the UK and the US in the study of inherited disease and the neuroprotective molecular medicines used to treat them. He is a leading expert in the area of inherited disorders affecting serotonin, catecholamine, folate, and pyridoxal phosphate metabolism.
Dr. Hyland has been honored for his work in the area of Neurometabolic Disease, including the Noel Raine Award from the Society for the Study of Inborn Errors of Metabolism (1989 and 1998).
Dr. Langley attained two bachelor degrees from the University of North Carolina at Chapel Hill in Biology and Clinical Laboratory Science. He subsequently worked as a Medical Technologist in the Core Lab of McLendon Clinical Laboratories at the University of North Carolina Hospitals, gaining experience in clinical laboratory operations. Dr. Langley went on to attain a PhD in Microbiology and Molecular Genetics from Emory University.
Dr. Langley has published on topics ranging from human genetics and immunology, to the development of novel anthrax and influenza vaccines.
Dr. Langley is certified by the New York State Department of Health as a Laboratory Director in the area of Genetic Testing (Molecular).
Dr. Volpe graduated from Duke University in 2008 with PhD in computational biology and bioinformatics, with a concentration in immunology. His research involved developing a software algorithm to decipher the germline origins of human immunoglobulin and T-cell receptors and then using that software to analyze large data sets of human antibodies to understand their diversity. He received the American Association of Immunologists-Huang Foundation Young Investigator Award in 2007 for his work in anti-HIV antibody composition. Upon graduating, Dr. Volpe worked as a Medical Science Liaison at Monogram Biosciences where he covered the Southeast and Midwest territories. In early 2016, he became the Director of Scientific Outreach, helping to build the Medical Science Liaison team for LabCorp.
In early 2018, Dr. Volpe began putting together the pieces of what would become LabCorp’s Partners in Clinical Neuroscience program and he is now the National Segment Director for that program. He is an author on seven peer-reviewed articles and eight conference posters. In 2011, he was a LabCorp Chairman’s Award winner and was also the Monogram Biosciences MVP awardee.